hotspot -WSS

hotspot

author：fashion 2025-10-01 17:19:23 - browse：4621

Editor’s note: A recording of the event is embedded below.

Now that biosimilar versions of Humira are starting to arrive, what happens next? Will this finally prove the case that biosimilars can deliver on big health care savings? What key signals will indicate how biosimilars might be prescribed, or paid for?

Let’s dive in and discuss what to watch in the months ahead.

Speakers:

Alex Brill, CEO, Matrix Global Advisors
Chris Brown, managing partner and co-founder, Integrity Rx Partners
Fran Gregory, PharmD, vice president of emerging therapies, Cardinal Health
Michael Gonzales, independent health care consultant, Michael Gonzales, LLC; former national and regional account director, AbbVie
Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)
Thomas Newcomer, head of U.S. market access, Samsung Bioepis (sponsor speaker)

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： How housing is health care on Long Island

focus

WSS

Regeneron agrees to White House price limits on anti

Telehealth for opioid use disorder is lifesaving

Food makers to regulators: Ultra

FDA proposes changes to key medical devices approval pathway

Physician groups backed by private equity giant lobby on mergers

A common UTI test for kids haunts adults as a traumatic 'nightmare'

focus

hotspot

focus

Guidelines to prevent youth baseball injuries need more muscle

National panel will explore requiring free Covid tests

After affirmative action ruling, medical educators look to 'holistic review'

How to make the FDA’s new prescription one

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

FDA panel endorses Alnylam’s heart drug — after picking it apart

New air purifier tech could be key to improving indoor air quality

Walmart eyes Medicare Advantage provider ChenMed

Hepatitis C has a cure — but many Americans still lack access to it

Infectious disease expert Jeanne Marrazzo assumes Fauci role

hotspot

FDA panel endorses Alnylam’s heart drug — after picking it apart

Sage hopes for a blockbuster in antidepressant now before FDA

Walmart eyes Medicare Advantage provider ChenMed

New weight loss drugs vying to be the next Wegovy or Mounjaro

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

Physician groups backed by private equity giant lobby on mergers

hotspot

hotspot

focus

explore